X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (4) 4
humans (4) 4
index medicus (4) 4
middle aged (4) 4
aged (3) 3
chemotherapy (3) 3
disease-free survival (3) 3
male (3) 3
antimitotic agents (2) 2
antineoplastic agents (2) 2
carboplatin (2) 2
carcinoma, non-small-cell lung - drug therapy (2) 2
carcinoma, non-small-cell lung - mortality (2) 2
care and treatment (2) 2
cisplatin (2) 2
gemcitabine (2) 2
lung cancer (2) 2
lung cancer, non-small cell (2) 2
lung neoplasms - drug therapy (2) 2
lung neoplasms - mortality (2) 2
oncology (2) 2
proportional hazards models (2) 2
prospective studies (2) 2
treatment outcome (2) 2
tumors (2) 2
abridged index medicus (1) 1
acute-renal-failure (1) 1
adjuvants (1) 1
administration, oral (1) 1
administrative support (1) 1
adolescent (1) 1
adult (1) 1
agriculture (1) 1
anemia (1) 1
animals (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic agents - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
cancer (1) 1
cancer therapies (1) 1
carboplatin - administration & dosage (1) 1
carboplatin/paclitaxel (1) 1
carcinoma (1) 1
carcinoma, non-small-cell lung - diagnosis (1) 1
carcinoma, non-small-cell lung - enzymology (1) 1
carcinoma, non-small-cell lung - genetics (1) 1
carcinoma, non-small-cell lung - pathology (1) 1
cell biology (1) 1
cell proliferation (1) 1
cells, cultured (1) 1
chi-square distribution (1) 1
cisplatin - administration & dosage (1) 1
clinical trials (1) 1
combination (1) 1
cyclin d1 - genetics (1) 1
cyclin d1 - metabolism (1) 1
cyclin e - genetics (1) 1
cyclin e - metabolism (1) 1
cyclin-dependent kinase 2 - genetics (1) 1
cyclin-dependent kinase 2 - metabolism (1) 1
cyclin-dependent kinase inhibitor p27 - genetics (1) 1
cyclin-dependent kinase inhibitor p27 - metabolism (1) 1
data collection (1) 1
data processing (1) 1
deoxycytidine - administration & dosage (1) 1
deoxycytidine - analogs & derivatives (1) 1
description and travel (1) 1
diabetic nephropathies - metabolism (1) 1
diabetic nephropathies - pathology (1) 1
docetaxel (1) 1
dosage and administration (1) 1
double-blind method (1) 1
drug administration schedule (1) 1
drug therapy (1) 1
drug therapy, combination (1) 1
drugs (1) 1
duration (1) 1
early ovarian cancer (1) 1
epidermal growth factor receptors (1) 1
erlotinib (1) 1
erlotinib hydrochloride (1) 1
europe (1) 1
exanthema (1) 1
exons (1) 1
expression (1) 1
fallopian-tube (1) 1
fatigue - chemically induced (1) 1
gefitinib (1) 1
gene deletion (1) 1
glomerulonephritis (1) 1
glutamates - adverse effects (1) 1
glutamates - therapeutic use (1) 1
growth-factor-beta (1) 1
guanine - adverse effects (1) 1
guanine - analogs & derivatives (1) 1
guanine - therapeutic use (1) 1
health aspects (1) 1
hematology, oncology and palliative medicine (1) 1
high glucose (1) 1
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Rosell, Rafael, Dr and Carcereny, Enric, MD and Gervais, Radj, MD and Vergnenegre, Alain, Prof and Massuti, Bartomeu, MD and Felip, Enriqueta, MD and Palmero, Ramon, MD and Garcia-Gomez, Ramon, MD and Pallares, Cinta, MD and Sanchez, Jose Miguel, MD and Porta, Rut, MD and Cobo, Manuel, MD and Garrido, Pilar, MD and Longo, Flavia, MD and Moran, Teresa, MD and Insa, Amelia, MD and De Marinis, Filippo, MD and Corre, Romain, MD and Bover, Isabel, MD and Illiano, Alfonso, MD and Dansin, Eric, MD and de Castro, Javier, MD and Milella, Michele, MD and Reguart, Noemi, MD and Altavilla, Giuseppe, MD and Jimenez, Ulpiano, MD and Provencio, Mariano, MD and Moreno, Miguel Angel, MD and Terrasa, Josefa, MD and Muñoz-Langa, Jose, MD and Valdivia, Javier, MD and Isla, Dolores, MD and Domine, Manuel, MD and Molinier, Olivier, MD and Mazieres, Julien, Prof and Baize, Nathalie, MD and Garcia-Campelo, Rosario, MD and Robinet, Gilles, MD and Rodriguez-Abreu, Delvys, MD and Lopez-Vivanco, Guillermo, MD and Gebbia, Vittorio, MD and Ferrera-Delgado, Lioba, MD and Bombaron, Pierre, MD and Bernabe, Reyes, MD and Bearz, Alessandra, MD and Artal, Angel, MD and Cortesi, Enrico, MD and Rolfo, Christian, MD and Sanchez-Ronco, Maria, PhD and Drozdowskyj, Ana, PhD and Queralt, Cristina, PhD and de Aguirre, Itziar, PhD and Ramirez, Jose Luis, PhD and Sanchez, Jose Javier, Prof and Molina, Miguel Angel, PhD and Taron, Miquel, PhD and Paz-Ares, Luis, MD and Assoc Italiana Oncologia Toracica and Grp Francais Pneumocancerologie and Spanish Lung Cancer Group in collaboration with Groupe Français de Pneumo-Cancérologie and Associazione Italiana Oncologia Toracica
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 3, pp. 239 - 246
Summary Background Erlotinib has been shown to improve progression-free survival compared with chemotherapy when given as first-line treatment for Asian... 
Hematology, Oncology and Palliative Medicine | IPASS | GEFITINIB | THERAPY | ONCOLOGY | SENSITIVITY | CARBOPLATIN/PACLITAXEL | TUMORS | Erlotinib Hydrochloride | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Prospective Studies | Exons | Lung Neoplasms - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - pathology | Male | Protein Kinase Inhibitors - adverse effects | Molecular Targeted Therapy | Cisplatin - administration & dosage | Patient Selection | Time Factors | Female | Quinazolines - administration & dosage | Precision Medicine | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Lung Neoplasms - enzymology | Drug Administration Schedule | Administration, Oral | Carcinoma, Non-Small-Cell Lung - genetics | Deoxycytidine - administration & dosage | Europe | Kaplan-Meier Estimate | Proportional Hazards Models | Carboplatin - administration & dosage | Treatment Outcome | Chi-Square Distribution | Carcinoma, Non-Small-Cell Lung - mortality | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Taxoids - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Quinazolines - therapeutic use | Quinazolines - adverse effects | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Carcinoma, Non-Small-Cell Lung - enzymology | Mutation | Deoxycytidine - analogs & derivatives | Antimitotic agents | Care and treatment | Chemotherapy | Erlotinib | Lung cancer | Product development | Agriculture | Lung cancer, Non-small cell | Antineoplastic agents | Standards | Cancer
Journal Article
Lancet, The, ISSN 0140-6736, 2009, Volume 374, Issue 9699, pp. 1432 - 1440
Journal Article
Journal Article
1840, 2a edicion, corregida é ilustrada con abundantes notas y documentos, y continuada hasta nuestros dias por el D.D. Miguel Moragues Pro y D. Joaquin Maria Bover., 3 v.
Book
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.